Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
| ETAGX Fund | USD 50.19 0.03 0.06% |
Slightly above 61% of Eventide Gilead's investor base is looking to short. The analysis of overall sentiment of trading Eventide Gilead mutual fund suggests that many investors are alarmed at this time. Eventide Gilead's investing sentiment can be driven by a variety of factors including economic data, Eventide Gilead's earnings reports, geopolitical events, and overall market trends.
Eventide |
Filed transaction by Sarepta Therapeutics Officer: Chief Customer Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at zacks.com
 |
Eventide Gilead Fundamental Analysis
We analyze Eventide Gilead's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eventide Gilead using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eventide Gilead based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Eventide Gilead is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Eventide Gilead Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eventide Gilead mutual fund to make a market-neutral strategy. Peer analysis of Eventide Gilead could also be used in its relative valuation, which is a method of valuing Eventide Gilead by comparing valuation metrics with similar companies.
Peers
Eventide Gilead Related Equities
| ETIEX | Eventide Exponential | 2.24 | ||||
| 70082LAB3 | 70082LAB3 | 1.58 | ||||
| VIASP | Via Renewables | 0.94 | ||||
| MSTSX | Morningstar Unconstrained | 0.37 | ||||
| ETIDX | Eventide Global | 0.11 | ||||
| ETGLX | Eventide Gilead | 0.08 | ||||
| LBHIX | Thrivent High | 0.24 | ||||
| RRTLX | T Rowe | 2.90 |
Other Information on Investing in Eventide Mutual Fund
Eventide Gilead financial ratios help investors to determine whether Eventide Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eventide with respect to the benefits of owning Eventide Gilead security.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |